BF
NBRV

BOK Financial’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

BOK Financial’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$13K – 952
2020
Q3 		$13K Buy
100
+40
+67% +$6.69K ﹤0.01% 852
2020
Q2 		$10K Buy
+60
New +$10K ﹤0.01% 848

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

BOK Financial's NBRV Position: Q4 2020 in Review

BOK Financial sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 100 shares — an estimated $13K sold.

BOK Financial first reported a position in NBRV in Q2 2020 and held it in 2 quarters. The position peaked at $13K in Q3 2020. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

  • BOK Financial reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
  • BOK Financial sold 100 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $13K.
  • BOK Financial first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2020 and held it in 2 quarters.
  • BOK Financial's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $13K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on BOK Financial's 13F filing for Q4 2020, filed 12 Feb 2021.